Search results
AstraZeneca beats revenue, profit estimates on resilient demand
Reuters· 1 hour agoAstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by...
US Senate committee investigates pricing of Novo's Ozempic and Wegovy
Reuters via AOL· 13 hours agoCommittee on Health, Education, Labor and Pensions, sent a letter to Novo's CEO seeking more...
Amid claims a CT company is selling lethal injection drugs, lawmakers push for a ban
The News-Times· 22 hours agoConnecticut lawmakers are vowing to push for legislation that would bar any company in the state...
US Senate committee investigates pricing of Novo's Ozempic and Wegovy By Reuters
Investing.com· 13 hours agoCommittee on Health, Education, Labor and Pensions, sent a letter to Novo's CEO seeking more...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 13 hours agoRecently, the European Commission approved Pfizer's Prevnar 20, a vaccine to help protect babies and...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 13 hours agoOn Feb. 22, the day of its December-quarter earnings release, Moderna stock surged above its 50-day...
Vertex has top orphan drug in the pipeline, as pharma eyes shiny obesity drugs: report
FierceBiotech· 1 day agoThe med has a net present value of $5.801 billion, with $1.26 billion in sales expected by 2028....
Treatment Patch For Schizophrenia: Newly Listed Alto Neuroscience Is Uniquely Positioned In...
Benzinga via Yahoo Finance· 1 day agoNeuroscience Inc (NYSE:ANRO) released results from its healthy volunteer Phase 1 study of ALTO-101,...
Should Eli Lilly (LLY) Be in Your Portfolio Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 18 hours agoA better-ranked biotech stock is ADMA Biologics ADMA, sporting a Zacks Rank #1 (Strong Buy). You can...
Biophytis Announces Transfer of ADSs to OTC Market
Digital Journal· 10 hours agoAbout BIOPHYTIS Biophytis SA is a clinical-stage biotechnology company specializing in the development of drug candidates for age-related diseases. BIO101 ...